Alprostadil and Dizziness - a phase IV clinical study of FDA data

Summary:

Dizziness is reported as a side effect among people who take Alprostadil (alprostadil), especially for people who are male, 60+ old, have been taking the drug for < 1 month also take Maraviroc, and have Gastric disorder.

The phase IV clinical study analyzes which people have Dizziness when taking Alprostadil. It is created by eHealthMe based on reports of 2,637 people who have side effects when taking Alprostadil from the FDA, and is updated regularly.

What is Alprostadil?

Alprostadil has active ingredients of alprostadil. It is often used in erection problems. eHealthMe is studying from 2,653 Alprostadil users. Check the latest studies of Alprostadil.

What is Dizziness?

Dizziness is found to be associated with 3,570 drugs and 5,711 conditions by eHealthMe. Check the latest studies of Dizziness.

On Aug, 10, 2026

2,637 people reported to have side effects when taking Alprostadil.
Among them, 37 people (1.4%) have Dizziness.

Among these 37 people:

How long have people been on Alprostadil when they have Dizziness? *

What is the gender of people who have Dizziness when taking Alprostadil? *

female: 34.29 %
male: 65.71 %

What is the age of people who have Dizziness when taking Alprostadil? *

What are other drugs people take besides Alprostadil? *

What are other side effects people have besides Dizziness? *

Meniere's Disease (a disorder of the inner ear that can affect hearing and balance to a varying degree): 9 people, 24.32%
Headache (pain in head): 8 people, 21.62%
Subacute Hepatic Failure: 5 people, 13.51%
Hepatic Encephalopathy (spectrum of neuropsychiatric abnormalities in patients with liver failure): 5 people, 13.51%
Hepatitis (inflammation of the liver): 5 people, 13.51%
Disseminated Intravascular Coagulation (systemic activation of blood coagulation): 5 people, 13.51%
Malaise (a feeling of general discomfort or uneasiness): 5 people, 13.51%
Nausea And Vomiting: 5 people, 13.51%
Abdominal Pain Upper: 5 people, 13.51%
Confusional State: 4 people, 10.81%

What are the existing conditions these people have? *

Fungal Nail Infection: 5 people, 13.51%
Gastric Disorder (disease of stomach): 5 people, 13.51%
High Blood Pressure: 4 people, 10.81%
Hyperlipidaemia (presence of excess lipids in the blood): 3 people, 8.11%
Pain: 2 people, 5.41%
Systemic Sclerosis (Scleroderma) (an autoimmune or connective tissue disease. it is characterized by thickening of the skin): 2 people, 5.41%
Hyperuricaemia (level of uric acid in the blood that is abnormally high): 2 people, 5.41%
Insomnia (sleeplessness): 2 people, 5.41%
Abdominal Discomfort: 2 people, 5.41%
Scleroderma Renal Crisis (malignant hypertension develops and causes acute renal failure was once a common cause of death): 2 people, 5.41%

* Approximation only. Some reports may have incomplete information.

Do you take Alprostadil and have Dizziness?

- Check whether Dizziness is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Alprostadil:

Alprostadil (2,653 reports)

Dizziness treatments and more:

Dizziness (613,962 reports)

Browse all side effects of Alprostadil:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Dizziness:

Dizziness (3,570 drugs)

Browse all the conditions that are associated with Dizziness:

Dizziness (5,711 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on alprostadil (the active ingredients of Alprostadil) and Alprostadil (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.